Literature DB >> 12095550

Expression of hypoxia-inducible factor-1alpha in cervical carcinomas: correlation with tumor oxygenation.

Hans Kristian Haugland1, Vojislav Vukovic, Melania Pintilie, Anthony W Fyles, Michael Milosevic, Richard P Hill, David W Hedley.   

Abstract

PURPOSE: To investigate the relations between hypoxia-inducible factor-1 (HIF-1), tumor oxygenation, and clinical correlates in patients with locally advanced carcinoma of the uterine cervix. METHODS AND MATERIALS: Biopsies from 42 patients with invasive cervical carcinoma and previous polarographic O2 measurements were assessed for the expression of HIF-1alpha using digitized microscopic imaging and analysis.
RESULTS: The HIF-1alpha expression levels ranged from <0.1% to 10.7% of the total tumor area; the positive staining was localized exclusively to the nuclei. Three distinct arrangement patterns of HIF-1alpha-positive cells in relation to blood vessels were identified using spatial image mapping: (1) most HIF-1alpha-positive cells were located within the typical oxygen diffusion distance in tissue (< or =150 microm to the nearest blood vessel); (2) most HIF-1alpha-positive cells were located in the vicinity (< or =60 microm) of the blood vessels; and (3) no apparent spatial relationship was found between HIF-1alpha-positive cells and blood vessels. A statistically significant association was found between HIF-1alpha expression and tumor oxygenation (Spearman correlation coefficient = 0.4, p <0.01), as determined with the Eppendorf pO2 histograph. No correlation was found between the level of HIF-1alpha expression and patient outcome, using disease-free survival as the end point.
CONCLUSION: Our results suggest that HIF-1alpha expression may represent a useful biologic marker for hypoxia in uterine cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12095550     DOI: 10.1016/s0360-3016(02)02815-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  18 in total

1.  Association of progressive structural changes in the bronchial epithelium with subepithelial fibrous remodeling: a potential role for hypoxia.

Authors:  Vasiliy V Polosukhin; William E Lawson; Aaron P Milstone; Svetlana M Egunova; Andrey G Kulipanov; Sergey G Tchuvakin; Pierre P Massion; Timothy S Blackwell
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

2.  A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells.

Authors:  Stefania Merighi; Annalisa Benini; Prisco Mirandola; Stefania Gessi; Katia Varani; Edward Leung; Stephen MacLennan; Pier Giovanni Baraldi; Pier Andrea Borea
Journal:  Neoplasia       Date:  2005-10       Impact factor: 5.715

3.  Preliminary clinical study of weekly recombinant human endostatin as a hypoxic tumour cell radiosensitiser combined with radiotherapy in the treatment of NSCLC.

Authors:  Xiao-Dong Jiang; Yun Qiao; Peng Dai; Jin Wu; Da-An Song; Shi-Qiu Li; Yue-Wei Fan
Journal:  Clin Transl Oncol       Date:  2012-06       Impact factor: 3.405

Review 4.  Clinical biomarkers for hypoxia targeting.

Authors:  Quynh-Thu Le; Don Courter
Journal:  Cancer Metastasis Rev       Date:  2008-09       Impact factor: 9.264

5.  Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha.

Authors:  Sreenivasulu Chintala; Károly Tóth; Shousong Cao; Farukh A Durrani; Mary M Vaughan; Randy L Jensen; Youcef M Rustum
Journal:  Cancer Chemother Pharmacol       Date:  2010-01-12       Impact factor: 3.333

Review 6.  Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?

Authors:  Robert J Gillies; Robert A Gatenby
Journal:  J Bioenerg Biomembr       Date:  2007-06       Impact factor: 2.945

7.  Microregional antitumor activity of a small-molecule hypoxia-inducible factor 1 inhibitor.

Authors:  Kiyoshi Okamoto; Daisuke Ito; Kazuki Miyazaki; Saori Watanabe; Osamu Tohyama; Akira Yokoi; Yoichi Ozawa; Makoto Asano; Takanori Kawamura; Yoshinobu Yamane; Satoshi Nagao; Setsuo Funasaka; Junichi Kamata; Yoshihiko Kotake; Mika Aoki; Naoko Tsukahara; Yoshiharu Mizui; Isao Tanaka; Kohei Sawada
Journal:  Int J Mol Med       Date:  2011-12-29       Impact factor: 4.101

8.  Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas.

Authors:  S-C Chou; Y Azuma; M A Varia; J A Raleigh
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

9.  Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas.

Authors:  Ingeborg M Bachmann; Rita G Ladstein; Oddbjørn Straume; George N Naumov; Lars A Akslen
Journal:  BMC Cancer       Date:  2008-12-05       Impact factor: 4.430

10.  Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?

Authors:  Günther Gruber; Richard H Greiner; Ruslan Hlushchuk; Daniel M Aebersold; Hans J Altermatt; Gilles Berclaz; Valentin Djonov
Journal:  Breast Cancer Res       Date:  2004-03-09       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.